GHUCCTS

News

Share This
  • Aug 17, 2020

GHUCCTS KL2 scholar alumna Dr. Seble Kassaye leads development of confidential COVID-19 symptom tracking tool


Infectious disease expert Dr. Seble Kassaye, associate professor of medicine at Georgetown University Medical Center (GUMC) and former GHUCCTS KL2 scholar, led a team of researchers to develop an online COVID-19 symptom tracking tool. The tool ensures a person’s confidentiality while being able to actively monitor their symptoms.

“Our online system provides a method for efficient, active monitoring of large numbers of individuals under quarantine or home isolation, while maintaining privacy” says Dr. Kassaye in a recent news release from GUMC. Recognizing the urgent need for this kind of technology, the team developed the initial tool in just five days. The team launched the app in March 2020, using 48 medical students as a pilot group. Since then, the team had released a Spanish language version and hope to pursue mobile and voice-activated versions of the tool.

The tracker can be viewed at www.covidgu.org.

Related News

TBS Grant Writing Workshop (GWW) Series registration is now open for the 2021-2022 cycle.

Sep 08, 2021

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Translational Biomedical Science (TBS) Program is offering a 6 month Grant Writing Workshop Series

GHUCCTS announces 2021 KL2 Scholars Dr. Maurice Fluitt & Dr. Roxanne Mirabal-Beltran

Aug 10, 2021

After our 11th highly competitive application cycle, unfortunately delayed due to COVID-related research closures, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Dr. Maurice Fluitt and Dr. Roxanne Mirabal-Beltran as a KL2 Scholar.

GHUCCTS featured in National Black Nurses Association for Howard University's Novavax COVID-19 Clinical Trial

May 28, 2021

GHUCCTS is featured in the Winter 2021 edition of the National Black Nurses Association (NBNA) Newsletter for our work helping with the planning, recruitment, and implementation efforts of the Novavax COVID-19 vaccine study at Howard University.

Close